Retatrutide, an experimental weight loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam retatrutide clinical trial saudi arabia Clinical trial results for retatrutide, Eli Lilly's next weight loss drug, AstraZeneca scraps another GLP 1 candidate against type 2 diabetes Novo Nordisk announces that CVS Caremark, the country's largest PBM, has decided Wegovy will be the preferred GLP 1 medicine covered for obesity on its template formularies Low Dose Naltrexone (LDN) for Fibromyalgia: A Pain & Fatigue Relief We still have affordable GLP 1 options available to Eligible members! Pricing as low as $25 with insurance or $149 without.* Free Rx delivery for our Plus Members *Prescription Required. Restrictions apply.